• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.严重再生障碍性贫血患者外周血端粒长度和克隆性染色体改变。
Br J Haematol. 2024 Sep;205(3):1180-1187. doi: 10.1111/bjh.19681. Epub 2024 Aug 5.
2
Hemophagocytic Lymphohistiocytosis Gene Variants in Severe Aplastic Anemia and Their Impact on Hematopoietic Cell Transplantation Outcomes.噬血细胞性淋巴组织细胞增生症基因变异在重型再生障碍性贫血中的作用及其对造血干细胞移植结局的影响。
Transplant Cell Ther. 2024 Aug;30(8):770.e1-770.e10. doi: 10.1016/j.jtct.2024.05.017. Epub 2024 May 27.
3
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比,HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
4
Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.与免疫抑制疗法相比,同胞全相合供者干细胞移植治疗获得性重型再生障碍性贫血:一项Cochrane系统评价
BMJ Open. 2014 Jul 15;4(7):e005039. doi: 10.1136/bmjopen-2014-005039.
5
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.先天性角化不良/端粒生物学障碍患者因骨髓衰竭或骨髓增生异常综合征行异基因造血细胞移植:不使用放疗的非清髓性预处理、单中心、单臂、开放标签试验。
Transplant Cell Ther. 2024 Oct;30(10):1005.e1-1005.e17. doi: 10.1016/j.jtct.2024.07.007. Epub 2024 Jul 11.
6
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective.从动态系统视角理解造血细胞移植中的端粒生物学
medRxiv. 2025 Jan 22:2025.01.20.24319630. doi: 10.1101/2025.01.20.24319630.
7
G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Severe Aplastic Anemia Patients.粒细胞集落刺激因子动员的外周血干细胞单倍型相合移植可为重型再生障碍性贫血患者带来满意的临床疗效。
Transplant Cell Ther. 2025 Jul;31(7):454.e1-454.e11. doi: 10.1016/j.jtct.2025.04.008. Epub 2025 Apr 19.
8
Upfront Haploidentical Hematopoietic Cell Transplantation Using αβ T Cell-Depleted Peripheral Blood Stem Cells for Pediatric Patients with Acquired Severe Aplastic Anemia.使用αβ T细胞去除的外周血干细胞对获得性重型再生障碍性贫血患儿进行一线单倍体相合造血细胞移植
Transplant Cell Ther. 2025 Jun 10. doi: 10.1016/j.jtct.2025.06.012.
9
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective.从动态系统角度理解造血细胞移植中的端粒生物学
Transplant Cell Ther. 2025 Jul 1. doi: 10.1016/j.jtct.2025.06.024.
10
Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.儿童异基因造血细胞移植受者弥漫性肺泡出血的流行病学
Transplant Cell Ther. 2024 Oct;30(10):1017.e1-1017.e12. doi: 10.1016/j.jtct.2024.07.022. Epub 2024 Jul 31.

引用本文的文献

1
Current view on the etiopathogenesis of aplastic anemia.再生障碍性贫血病因发病机制的当前观点。
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):399-408. doi: 10.4196/kjpp.24.214. Epub 2025 Apr 28.
2
Association Between Telomere Shortening and Erythropoietin Resistance in Patients with Chronic Kidney Disease Undergoing Hemodialysis.接受血液透析的慢性肾脏病患者端粒缩短与促红细胞生成素抵抗之间的关联
Int J Mol Sci. 2025 Apr 5;26(7):3405. doi: 10.3390/ijms26073405.

本文引用的文献

1
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?再生障碍性贫血中的克隆进化:肿瘤监测失败还是适应性恢复不良?
Leuk Lymphoma. 2023 Jul-Aug;64(8):1389-1399. doi: 10.1080/10428194.2023.2215614. Epub 2023 Jun 25.
2
Molecular landscape of immune pressure and escape in aplastic anemia.再生障碍性贫血中免疫压力和逃逸的分子特征。
Leukemia. 2023 Jan;37(1):202-211. doi: 10.1038/s41375-022-01723-w. Epub 2022 Oct 17.
3
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.不同种族再生障碍性贫血患者 HLA Ⅰ类等位基因的致病性和影响。
JCI Insight. 2022 Nov 22;7(22):e163040. doi: 10.1172/jci.insight.163040.
4
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.胚系-体细胞 JAK2 相互作用与骨髓纤维化中的克隆扩张有关。
Nat Commun. 2022 Sep 8;13(1):5284. doi: 10.1038/s41467-022-32986-7.
5
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.在严重再生障碍性贫血中进行基因检测对造血细胞移植的结果至关重要。
Blood. 2022 Aug 25;140(8):909-921. doi: 10.1182/blood.2022016508.
6
Polygenic basis and biomedical consequences of telomere length variation.端粒长度变化的多基因基础和生物医学后果。
Nat Genet. 2021 Oct;53(10):1425-1433. doi: 10.1038/s41588-021-00944-6. Epub 2021 Oct 5.
7
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.端粒较短预示骨髓增生异常综合征患者干细胞移植后非复发死亡率。
Blood. 2020 Dec 24;136(26):3070-3081. doi: 10.1182/blood.2020005397.
8
Genetically predicted telomere length is associated with clonal somatic copy number alterations in peripheral leukocytes.遗传预测的端粒长度与外周血白细胞中的克隆性体细胞拷贝数改变有关。
PLoS Genet. 2020 Oct 22;16(10):e1009078. doi: 10.1371/journal.pgen.1009078. eCollection 2020 Oct.
9
Monogenic and polygenic inheritance become instruments for clonal selection.单基因遗传和多基因遗传成为克隆选择的工具。
Nature. 2020 Aug;584(7819):136-141. doi: 10.1038/s41586-020-2430-6. Epub 2020 Jun 24.
10
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.获得性再生障碍性贫血和阵发性睡眠性血红蛋白尿症中的继发性骨髓增生异常综合征和白血病。
Blood. 2020 Jul 2;136(1):36-49. doi: 10.1182/blood.2019000940.

严重再生障碍性贫血患者外周血端粒长度和克隆性染色体改变。

Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Br J Haematol. 2024 Sep;205(3):1180-1187. doi: 10.1111/bjh.19681. Epub 2024 Aug 5.

DOI:10.1111/bjh.19681
PMID:39103182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499016/
Abstract

Severe aplastic anaemia (SAA) is a rare and life-threatening bone marrow failure disorder. We used data from the transplant outcomes in aplastic anaemia study to characterize mosaic chromosomal alterations (mCAs) in the peripheral blood of 738 patients with acquired SAA and evaluate their associations with telomere length (TL) and survival post-haematopoietic cell transplant (HCT). The median age at HCT was 20.4 years (range = 0.2-77.4). Patients with SAA had shorter TL than expected for their age (median TL percentile for age: 35.7th; range <1-99.99). mCAs were detected in 211 patients (28.6%), with chr6p copy-neutral loss of heterozygosity (6p-CNLOH) in 15.9% and chr7 loss in 3.0% of the patients; chrX loss was detected in 4.1% of female patients. Negative correlations between mCA cell fraction and measured TL (r = -0.14, p = 0.0002), and possibly genetically predicted TL (r = -0.07, p = 0.06) were noted. The post-HCT 3-year survival probability was low in patients with chr7 loss (39% vs. 72% in patients with chr6-CNLOH, 60% in patients with other mCAs and 70% in patients with no mCAs; p-log rank = 0.001). In multivariable analysis, short TL (p = 0.01), but not chr7 loss (p = 0.29), was associated with worse post-HCT survival. TL may guide clinical decisions in patients with SAA.

摘要

严重再生障碍性贫血(SAA)是一种罕见且危及生命的骨髓衰竭性疾病。我们利用再生障碍性贫血移植研究的移植结果数据,对 738 例获得性 SAA 患者外周血中的嵌合体染色体改变(mCA)进行了特征描述,并评估了它们与端粒长度(TL)和造血细胞移植(HCT)后生存的关系。HCT 时的中位年龄为 20.4 岁(范围=0.2-77.4)。SAA 患者的 TL 比预期年龄短(年龄的 TL 中位数百分位数:第 35.7 百分位数;范围<1-99.99)。211 例患者(28.6%)检测到 mCA,其中 15.9%的患者存在 6p 染色体杂合性丢失(6p-CNLOH),3.0%的患者存在 7 号染色体缺失;4.1%的女性患者检测到 X 染色体缺失。mCA 细胞分数与测量 TL 呈负相关(r=-0.14,p=0.0002),可能与遗传预测 TL 呈负相关(r=-0.07,p=0.06)。7 号染色体缺失患者的 HCT 后 3 年生存率较低(39%vs.6p-CNLOH 患者 72%,其他 mCA 患者 60%,无 mCA 患者 70%;p-log 秩=0.001)。多变量分析显示,短 TL(p=0.01)而不是 7 号染色体缺失(p=0.29)与 HCT 后生存不良相关。TL 可能指导 SAA 患者的临床决策。